Login / Signup

The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging.

Hae Lin ChoSubha PerniAnthony V D'AmicoKosj YamoahEdward Christopher Dee
Published in: Prostate cancer and prostatic diseases (2023)
Keyphrases
  • clinical trial
  • prostate cancer
  • high resolution
  • cancer therapy
  • benign prostatic hyperplasia
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • photodynamic therapy